Clinica Baviera SA
MAD:CBAV

Watchlist Manager
Clinica Baviera SA Logo
Clinica Baviera SA
MAD:CBAV
Watchlist
Price: 42.1 EUR 2.93% Market Closed
Market Cap: 686.7m EUR

Intrinsic Value

The intrinsic value of one CBAV stock under the Base Case scenario is 46.29 EUR. Compared to the current market price of 42.1 EUR, Clinica Baviera SA is Undervalued by 9%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CBAV Intrinsic Value
46.29 EUR
Undervaluation 9%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Clinica Baviera SA

Valuation History Unavailable

Historical valuation for CBAV cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CBAV?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Clinica Baviera SA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Clinica Baviera SA

Current Assets 47.7m
Cash & Short-Term Investments 38.6m
Receivables 4.7m
Other Current Assets 4.4m
Non-Current Assets 164m
Long-Term Investments 2.4m
PP&E 122.7m
Intangibles 37m
Other Non-Current Assets 1.9m
Efficiency

Free Cash Flow Analysis
Clinica Baviera SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Clinica Baviera SA

Revenue
262.6m EUR
Cost of Revenue
-30.6m EUR
Gross Profit
232.1m EUR
Operating Expenses
-176.4m EUR
Operating Income
55.6m EUR
Other Expenses
-15.4m EUR
Net Income
40.2m EUR
Fundamental Scores

CBAV Profitability Score
Profitability Due Diligence

Clinica Baviera SA's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
74/100
Profitability
Score

Clinica Baviera SA's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

CBAV Solvency Score
Solvency Due Diligence

Clinica Baviera SA's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
76/100
Solvency
Score

Clinica Baviera SA's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CBAV Price Targets Summary
Clinica Baviera SA

There are no price targets for CBAV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Jun 6, 2025
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for CBAV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CBAV Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CBAV stock?

The intrinsic value of one CBAV stock under the Base Case scenario is 46.29 EUR.

Is CBAV stock undervalued or overvalued?

Compared to the current market price of 42.1 EUR, Clinica Baviera SA is Undervalued by 9%.

Back to Top